Vasopressors and inotropes in cardiogenic shock: is there room for "adrenaline resuscitation"?
- PMID: 27677383
- PMCID: PMC5039816
- DOI: 10.1186/s13054-016-1459-2
Vasopressors and inotropes in cardiogenic shock: is there room for "adrenaline resuscitation"?
References
-
- Tarvasmäki T, Lassus J, Varpula M, Sionis A, Sund R, Køber L, Spinar J, Parissis J, Banaszewski M, Silva Cardoso J, Carubelli V, Di Somma S, Mebazaa A, Harjola VP, CardShock study investigators Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality. Crit Care. 2016;20:208–19. doi: 10.1186/s13054-016-1387-1. - DOI - PMC - PubMed
-
- Nieminen MS, Buerke M, Cohen-Solál A, Costa S, Edes I, Erlikh A, Franco F, Gibson C, Gorjup V, Guarracino F, Gustafsson F, Harjola VP, Husebye T, Karason K, Katsytadze I, Kaul S, Kivikko M, Marenzi G, Masip J, Matskeplishvili S, Mebazaa A, Møller JE, Nessler J, Nessler B, Ntalianis A, Oliva F, Pichler-Cetin E, Põder P, Recio-Mayoral A, Rex S, Rokyta R, Strasser RH, Zima E, Pollesello P. The role of levosimendan in acute heart failure complicating acute coronary syndrome: a review and expert consensus opinion. Int J Cardiol. 2016;218:150–7. doi: 10.1016/j.ijcard.2016.05.009. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
